Event Visit If it is thought that, based on information you provide, you might have had a stroke, TIA or heart attack, you will be scheduled for an evaluation. At the visit, you will: answer any questions about your study medications and any side effects or adverse events be evaluated using two scales, the modified Rankin Scale (mRS) and the NIH Stroke Scale (NIHSS) have your blood pressure taken complete another survey about any neurological symptoms you may have had since enrolling in the study. 90 Day Visit or Telephone Contact You will need to return to SFGH for a study visit 90 days after starting the study. At the up visit you will: answer questions about your study medications and any side effects or adverse events be evaluated using the modified Rankin Scale (mRS) and the NIH Stroke Scale (NIHSS) have your blood pressure taken complete another survey about any neurological symptoms you may have had since enrolling in the study If the visit is done by telephone, then you will: answer questions about your study medications and any side effects or adverse events be evaluated using the modified Rankin Scale complete the Stroke-Free and the Morisky Questionnaires At the end of the study, your treating physician will discuss with you the best choice for antiplatelet drugs like those in the study. Depending on costs, side effects, and your own preferences, clopidogrel, aspirin, or the medication aspirin/dipyridamole (also known as Aggrenox®) may be the best choice. If for some reason we are unable to locate you for the 90-Day follow visit, we will ask your alternate contact and/or review your medical chart to find out if you have been seen by another doctor within your hospital system and if you have had a stroke, TIA, or heart attack during the 90-Day follow up period. In order to make sure that we include the full 90-Day period in our review, we will need to review your chart after the 90 day study period has ended. This means that we may continue to collect information about you up to 150 days from your enrollment. How long will I be in the study?
Event Visit If it is thought that, based on information you provide, you might have had a stroke, TIA or heart attack, you will be scheduled for an evaluation. At the visit, you will: answer any questions about your study medications and any side effects or adverse events be evaluated using two scales, the modified Rankin Scale (mRS) and the NIH Stroke Scale (NIHSS) have your blood pressure taken complete another survey about any neurological symptoms you may have had since enrolling in the study. 90 Day Visit or Telephone Contact You will need to return to SFGH for a study visit 90 days after starting the study. At the visit you will: answer questions about your study medications and any side effects or adverse events be evaluated using the modified Rankin Scale (mRS) and the NIH Stroke Scale (NIHSS) have your blood pressure taken complete another survey about any neurological symptoms you may have had since enrolling in the study If the visit is done by telephone, then you will: answer questions about your study medications and any side effects or adverse events be evaluated using the modified Rankin Scale complete the Stroke-Free and the Morisky Questionnaires At the end of the study, your treating physician will discuss with you the best choice for antiplatelet drugs like those in the study. Depending on costs, side effects, and your own preferences, clopidogrel, aspirin, or the medication aspirin/dipyridamole (also known as Aggrenox®) may be the best choice. If for some reason we are unable to locate you for the 90-Day follow up visit, we will ask your alternate contact and/or review your medical chart to find out if you have been seen by another doctor within your hospital system and if you have had a stroke, TIA, or heart attack during the 90-Day follow up period. In order to make sure that we include the full 90-Day period in our review, we will need to review your chart after the 90 day study period has ended. This means that we may continue to collect information about you up to 150 days from your enrollment. How long will I be in the study?